Company
Orchid Ventures, Inc.
Headquarters: Vancouver, WA, United States
CEO: Mr. Corey Mangold
Market Cap
$524
USD as of July 1, 2023
Orchid Ventures, Inc. Categories
United States Healthcare Drug Manufacturers—Specialty & GenericUnited States Healthcare United States Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. The company provides cannabis vapor devices, such as kits and cartridges. It offers its products through approximately 150 dispensaries across California and Oregon. The company also licenses its brand and proprietary hardware to licensed manufacturers and distributors. It serves Cannabis and CBD industries. The company sells its products under the Orchid Essentials brand. Orchid Ventures, Inc. is headquartered in Ladera Ranch, California.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Orchid Ventures, Inc. has the following listings and related stock indices.
Stock: OTC: ORVRF wb_incandescent
Stock: CSE: ORCD wb_incandescent